These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24447592)

  • 21. Setting the target for a better cervical screening test: characteristics of a cost-effective test for cervical neoplasia screening.
    Myers ER; McCrory DC; Subramanian S; McCall N; Nanda K; Datta S; Matchar DB
    Obstet Gynecol; 2000 Nov; 96(5 Pt 1):645-52. PubMed ID: 11042294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for cervical cancer: new alternatives and research.
    Lörincz AT
    Salud Publica Mex; 2003; 45 Suppl 3():S376-87. PubMed ID: 14746031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
    Sarian LO; Derchain SF; Naud P; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Serpa-Hammes L; Matos J; Gontijo R; Bragança JF; Lima TP; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S; Syrjänen K
    J Med Screen; 2005; 12(3):142-9. PubMed ID: 16156945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Melnikow J; Henderson JT; Burda BU; Senger CA; Durbin S; Weyrich MS
    JAMA; 2018 Aug; 320(7):687-705. PubMed ID: 30140883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation.
    Takwoingi Y; Whitworth H; Rees-Roberts M; Badhan A; Partlett C; Green N; Boakye A; Lambie H; Marongiu L; Jit M; White P; Deeks JJ; Kon OM; Lalvani A
    Health Technol Assess; 2019 May; 23(23):1-152. PubMed ID: 31138395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy.
    Dinnes J; Deeks J; Kirby J; Roderick P
    Health Technol Assess; 2005 Mar; 9(12):1-113, iii. PubMed ID: 15774235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Random-effects meta-analysis of the clinical utility of tests and prediction models.
    Wynants L; Riley RD; Timmerman D; Van Calster B
    Stat Med; 2018 May; 37(12):2034-2052. PubMed ID: 29575170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Univariate and bivariate likelihood-based meta-analysis methods performed comparably when marginal sensitivity and specificity were the targets of inference.
    Dahabreh IJ; Trikalinos TA; Lau J; Schmid CH
    J Clin Epidemiol; 2017 Mar; 83():8-17. PubMed ID: 28063915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pap-smear analysis tool (PAT) for detection of cervical cancer from pap-smear images.
    William W; Ware A; Basaza-Ejiri AH; Obungoloch J
    Biomed Eng Online; 2019 Feb; 18(1):16. PubMed ID: 30755214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed diagnoses of cervical intraepithelial neoplasia and cancer after negative evaluation for atypical glandular cell pap smear: does age matter?
    Valdini AF; Augart CL; Olivieri M
    J Low Genit Tract Dis; 2013 Oct; 17(4):390-6. PubMed ID: 23609589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incorporating uncertainty regarding applicability of evidence from meta-analyses into clinical decision making.
    Kriston L; Meister R
    J Clin Epidemiol; 2014 Mar; 67(3):325-34. PubMed ID: 24332396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA detection in cervical exfoliated cells as a triage for human papillomavirus-positive women.
    Tian Q; Li Y; Wang F; Li Y; Xu J; Shen Y; Ye F; Wang X; Cheng X; Chen Y; Wan X; Lu W; Xie X
    J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25190727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The diagnostic value of serum hybrid capture 2 (CH2) HPV DNA in cervical cancer: a systematic review and meta-analysis.
    Yin D; Jiang Y; Wang N; Ouyang L; Lu Y; Zhang Y; Wei H; Zhang S
    Tumour Biol; 2014 Sep; 35(9):9247-53. PubMed ID: 24935474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with reduced accuracy in Papanicolaou tests for patients with invasive cervical cancer.
    Zhao L; Wentzensen N; Zhang RR; Dunn ST; Gold MA; Wang SS; Schiffman M; Walker JL; Zuna RE
    Cancer Cytopathol; 2014 Sep; 122(9):694-701. PubMed ID: 24888458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Summarising and validating test accuracy results across multiple studies for use in clinical practice.
    Riley RD; Ahmed I; Debray TP; Willis BH; Noordzij JP; Higgins JP; Deeks JJ
    Stat Med; 2015 Jun; 34(13):2081-103. PubMed ID: 25800943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-binomial meta-analysis of individual differences based on sample means and standard deviations: Studying reliability of sum scores of binary items.
    Doebler P; Frick S; Doebler A
    Psychol Methods; 2024 Mar; ():. PubMed ID: 38483524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discussion on the interpretation of the results and selection of the effect model in a meta-analysis.
    Tu J; Fang Q; Zhao A; Wu J
    Ann Palliat Med; 2022 Mar; 11(3):1153-1154. PubMed ID: 35272465
    [No Abstract]   [Full Text] [Related]  

  • 38. Discussion on the selection of the effect model in a meta-analysis.
    Fang Q; Wu J
    Ann Palliat Med; 2022 Dec; 11(12):3842-3843. PubMed ID: 36510464
    [No Abstract]   [Full Text] [Related]  

  • 39. The evidence synthesis and meta-analysis in R conference (ESMARConf): levelling the playing field of conference accessibility and equitability.
    Haddaway NR; Bannach-Brown A; Grainger MJ; Hamilton WK; Hennessy EA; Keenan C; Pritchard CC; Stojanova J
    Syst Rev; 2022 Jun; 11(1):113. PubMed ID: 35659294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is meta-analysis of RCTs assessing the efficacy of interventions a reliable source of evidence for therapeutic decisions?
    Maziarz M
    Stud Hist Philos Sci; 2022 Feb; 91():159-167. PubMed ID: 34922183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.